ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Gene Modified Immune Cells in Patients With Advanced Melanoma (F5)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00910650
Recruitment Status : Recruiting
First Posted : June 1, 2009
Last Update Posted : January 12, 2018
Sponsor:
Collaborators:
California Institute of Technology
University of Southern California
University of Connecticut
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Jonsson Comprehensive Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2018
  Estimated Study Completion Date : December 2019